Michael H M Chan
Consultant 顾问医生

hmchan@ha.org.hk


Biography
After graduating from the Faculty of Medicine, The Chinese University of Hong Kong in 1995, Dr Chan joined the Department of Chemical Pathology at Prince of Wales Hospital and pursued specialist training in Chemical Pathology. Since 2001, he has become a Fellow of the Royal College of Pathologists of Australasia, the Hong Kong College of Pathologists, the Hong Kong Academy of Medicine (Pathology) and Specialist in Chemical Pathology under the Medical Council of Hong Kong.



Dr Chan is actively involved in clinical service, research and teaching. Apart from serving as Duty Biochemist to advise on clinical consultations, he mainly functions as the Quality Manager for laboratory accreditation with the National Association of Testing Authority, Australia, Chairman of the NT East Cluster Point-of-care Testing (POCT) Co-ordinating Committee, and Cluster IT Committee for Pathology Services. At Cluster level, he is the Cluster Coordinator in Pathology.







As Honorary Clinical Associate Professor, Dr Chan also teaches medical students. His main research interests include heavy metals poisoning, toxicology, tumour markers, endocrinology, obesity, bone metabolism, inherited metabolism diseases as well as allergy & inflammatory diseases.


Selected publications:

Chan IHS, Kong APS, Leung TF, Tsui TK, Cheung RC, Osaki R, Ho CS, Wong GW, Wong CK, Lam CW, Chan JC, Chan MHM. Cadmium and lead in Hong Kong school children. Pathology 2012; 44: 626-31.

Wong CK, Chan MHM, Kwok JSS, Ho CS, Ng PC, Suen SH, Fung KP, Lau CM, Fok TF. Diagnostic tools for detection of intoxication by melamine and its analogue. Hong Kong Med J 2013; 19 Suppl: 12-5.

Lam HS, Lai WM, Wong SN, Chiu MC, Chu WC, Ng PC, Chan MHM, Lam CW, Tse NK, Kwong NS, Mak TW. Two-year follow-up for children with melamine exposure in Hong Kong: a multicentre study. Hong Kong Med J 2013; 19 Suppl: 10-1.

Kong AP, Choi KC, Ho CS, Chan MHM, Ozaki R, Chan CW, Chan JC. Association of uric acid and gamma-glutamyltransferase (GGT) with obesity and components of metabolic syndrome in children and adolescents. Pediatr Obes 2013; 8(5): 351-7.

Chan SL, Mo F, Johnson PJ, Siu DY, Chan MHM, Lau WY, Lai PB, Lam CW, Yeo W, Yu SC. Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass. HPB (Oxford) 2014; 16(4): 366-72.

Kong APS, Yang X, Luk A, Ma RCW, So WY, Ozaki R, Ting R, Cheung K, Ho CS, Chan MHM, Chow CC, Chan JCN. Severe hypoglycaemia identifies vulnerable patients with type 2 diabetes at risk of premature death and all-site cancer: The Hong Kong Diabetes Registry. Diabetes Care 2014; 37(4):1024-31.

Kong APS, Choi KC, Chan RS, Lok K, Ozaki R, Li AM, Ho CS, Chan MHM, Sea M, Henry CJ, Chan JC, Woo J. A randomized controlled trial to investigate the impact of a low glycemic index (GI) diet on body mass index in obese adolescents. BMC Public Health 2014; 14: 180.

Wing YK, Zhang JH, Lam J, Shirley BE, Ma RCW, Kong APS, Chan MHM, Ho CS, Li AM. A community-based study on the association between Insomnia and hypothalamic-pituitary-adrenal axis: Sex and pubertal influences. J Clin Endocrinol Metab 2014; 99(6): 2277-87.

Kong AP, Yang X, Luk A, Cheung KK, Ma RC, So WY, Ho CS, Chan MHM, Ozaki R, Chow CC, Brown N, Chan JC. Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: The Hong Kong Diabetes Registry. BMC Endocr Disord 2014; 14: 48.

Apple FS, Jaffe AS, Collinson P, Mockel M, Ordonez-Llanos J, Lindahl B, Hollander J, Plebani M, Than M, Chan MHM; on behalf of the International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 2015; 48(4-5):201-3.